Clinical Trials on Neoplasms, Genitourinary in Austria

Total 5565 results

Celgene

Completed

Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Among Healthcare Professionals (HCPs)

Myelodysplastic Syndromes | Beta-thalassemia

Austria
Ludwig Institute for Cancer Research
Bristol-Myers Squibb

Terminated

Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) Followed by Ipilimumab in Advanced Metastatic Melanoma

Metastatic Melanoma

Australia
Janssen Research & Development, LLC

Recruiting

A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-resistant Prostate Neoplasms

United States, Australia
Nativis, Inc.

Completed

A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia

Glioblastoma Multiforme

Australia
Neovii Biotech

Completed

Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection

Gastric Cancer | Gastric Adenocarcinoma

Austria, Spain, United Kingdom, Germany
Neovii Biotech

Terminated

Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment

Advanced Breast Cancer | Metastatic Breast Cancer

Spain, Austria, France, Germany, Italy
Sir Charles Gairdner Hospital

Completed

Catheter Over Needle vs Catheter Through Needle

Nerve Block | Catheterization

Australia
Peter MacCallum Cancer Centre, Australia
Varian Medical Systems

Recruiting

Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy (POPSTAR II)

Oligometastatic Prostate Cancer

Australia
Sanofi

Completed

Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF)

Breast Cancer | Prostatic Neoplasms

Australia
Ipsen

Completed

To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)

Gastro-Enteropancreatic Neuroendocrine Tumor

United States, Austria, Denmark
Peter MacCallum Cancer Centre, Australia

Recruiting

PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours (PARLuNET)

Neuroendocrine Tumors

Australia
Ludwig Institute for Cancer Research
Pfizer; Heidelberg Pharma AG

Terminated

Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma

Renal Cell Carcinoma (RCC)

Australia
Contact Asia Pacific

Unknown

Observation Only Study Involving Participants Enrolled in the CHAT Trial

Breast Cancer

Australia
Trans Tasman Radiation Oncology Group
Cancer Council New South Wales

Completed

SuperDEX Trial (Comparison of Two Doses of Dexamethasone for Malignant Spinal Cord Compression Treated by Radiotherapy).

Spinal Cord Compression From Neoplasm Metastasis

Australia
Medical University Innsbruck

Unknown

Characterization of Two Novel Mutations in the Apob Gene

Familial Hypobetalipoproteinaemia - Heterozygous Form | Low-LDL-syndrome

Austria
Genor Biopharma Co., Ltd.

Completed

Clinical Trial of Comparative Study of GB221 Pharmacokinetics

Metastatic Breast Cancer

Australia
Uptake Medical Technology, Inc.

Completed

Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE) (VAPORIZE)

Lung Cancer | Non Small Cell Lung Cancer | Metastatic Lung Cancer

Australia
Olivia Newton-John Cancer Research Institute
Merck Sharp & Dohme LLC; Viralytics

Active, not recruiting

Pembrolizumab + CVA21 in Advanced NSCLC

Non-Small Cell Lung Cancer

Australia
Monash University
The Alfred; University of Melbourne

Recruiting

Human Papillomavirus in Young People Epidemiological Research 4 (HYPER4)

Cancer | Anal Cancer | HPV Infection | HPV | Human Papillomavirus Infection | Men | HPV 16 Infection

Australia
Zhejiang Genfleet Therapeutics Co., Ltd.

Completed

A Study of GFH018 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China, Australia
Bayside Health
The Alfred; The Leukaemia Foundation of Victoria

Unknown

RCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMT

Hematological Malignancies

Australia
Trans Tasman Radiation Oncology Group

Completed

Chemoradiation Treatment for Head and Neck Cancer

Head and Neck Cancer

Australia
Maastricht University

Recruiting

The DRAGON 2 Trial (DRAGON 2)

Colorectal Cancer Liver Metastases (CRLM) | Small Future Liver Remnant (FLR)

Canada, Australia, Netherlands, Belgium, Sweden, Austria, Italy, Switzerland
Medical University of Graz

Recruiting

Observational Study on "Functional Overlay" in Patients With Movement Disorders

Parkinson Disease | Dystonia | Conversion Disorder | Tremor

Austria
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers

Bladder Cancer

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer (LuCAB)

Metastatic Castration-resistant Prostate Cancer | mCRPC

Australia
Ambrx, Inc.

Completed

A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)

Breast Neoplasms | Solid Tumors | Gastric Neoplasm

United States, Australia
Olivia Newton-John Cancer Research Institute
Austin Health; Merck Healthcare KGaA

Terminated

Bioimaging Study of 89Zr-M7824 in NSCLC

Non-Small Cell Lung Cancer

Australia
Trans Tasman Radiation Oncology Group

Completed

A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer (Local HER-O)

Breast Neoplasms

Australia
Clover Biopharmaceuticals AUS Pty Ltd

Completed

Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions

Malignant Pleural Effusions

Australia
Peter MacCallum Cancer Centre, Australia
Endocyte; Movember Foundation; Medical Research Future Fund; E.J. Whitten Foundation...

Active, not recruiting

Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy (LuTectomy)

Prostatic Neoplasms

Australia
Austin Health

Completed

Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)

Prostate Cancer

Australia
OncoMed Pharmaceuticals, Inc.
Celgene Corporation

Completed

A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer (DENALI)

Nonsquamous Nonsmall Cell Neoplasm of Lung

Spain, United States, Australia, Italy, Belgium
Iqvia Pty Ltd

Terminated

Phase I Trial of bacTRL-IL-12 in Adult Subjects With Advanced, Treatment-refractory Solid Tumours

Cancer - Solid Tumours

Australia
Australasian Gastro-Intestinal Trials Group

Recruiting

A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study (PALEO)

Oesophageal Cancer

Australia, New Zealand
Hummingbird Bioscience
Merck KGaA, Darmstadt, Germany

Recruiting

Study of an Anti-HER3 Antibody, HMBD-001, With Docetaxel +/- Cetuximab in Advanced Squamous Non-small Cell Lung Cancers

Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

Australia, Singapore
Blaze Bioscience Australia Pty Ltd

Completed

Safety Study of a Fluorescent Marker to Visualize Cancer Cells

Skin Neoplasms

Australia
Heidelberg University
Medical University of Graz; Medical University of Vienna; Hannover Medical School and other collaborators

Terminated

Evaluation of Votrient in Angiosarcoma (EVA)

Angiosarcoma

Germany, Austria
Evaxion Biotech A/S
Novotech (Australia) Pty Limited

Terminated

Study of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1

Melanoma Stage IV | Melanoma Stage III

Australia
Melanoma and Skin Cancer Trials Limited
Monash University

Completed

Improving Skin Cancer Management With Artificial Intelligence (04.17 SMARTI) (SMARTI)

Skin Cancer | Melanoma (Skin)

Australia
Dizal Pharmaceuticals

Not yet recruiting

DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin

Australia
Austin Health

Unknown

Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol (RADiChol)

Cholangiocarcinoma

Australia
Varian, a Siemens Healthineers Company

Recruiting

HyperArc Registry Study

Brain Metastases | CNS Neoplasm | CNS Disorder, Intracranial

United States, Australia
VASCage GmbH
Medical University Innsbruck; St John of God Hospital, Vienna

Recruiting

Stroke-Card Registry

Ischemic Stroke | Transient Ischemic Attack

Austria
Medical University of Graz
Winclove Probiotics B.V.; Institut AllergoSan

Completed

Probiotic Intervention in PCOS (ProPCO-RCT)

Polycystic Ovary Syndrome

Austria
Trans Tasman Radiation Oncology Group

Active, not recruiting

Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney (FASTRACK II)

Renal Cell Carcinoma

Australia
Antiva Biosciences

Completed

Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection

Cervical Cancer | Cervical Intraepithelial Neoplasia | CIN | Human Papilloma Virus | Cervical Dysplasia | HSIL of Cervix | Cervical Neoplasm | HSIL | High-Grade Squamous Intraepithelial Lesions | High-grade Cervical Intraepithelial Neoplasia

United States, Australia
Peter MacCallum Cancer Centre, Australia

Active, not recruiting

BEACON - ABC in Recurrent Platinum Resistant HGSOC (BEACON)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma

Australia
Bristol-Myers Squibb

Completed

A Study of Adjuvant Melanoma Stakeholder Treatment Preferences

Melanoma

Australia
Hoffmann-La Roche

Completed

A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid Tumours

Breast Cancer, Colorectal Cancer

New Zealand, Australia, United Kingdom

Clinical Trials on Neoplasms, Genitourinary in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations